The Modern Parenthood Institute today announced the launch of its Doctor of Integrative Parent Education (DIPE) program.

FDA Clears IND Allowing Phase 2a Trial of NAV-240 in Hidradenitis Suppurativa to Begin Dosing in Q1 2026HREC Approval ...

We ensured that all historical and new LED posts have been moved onto a new LED contract, which mimics the 2016 English ...

Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for ...

Z-endoxifen has demonstrated efficacy in phase 1 and 2 trials, improving progression-free survival and tumor response in ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on ...

Members of the profession have welcomed the focus on eye care and highlighted the important role of optometry practices in ...

Hair loss has always been emotionally loaded, but the science behind it is becoming unusually exciting. A wave of new drugs, ...

For decades, restoring sight after severe eye damage sat firmly in the realm of science fiction. Now a wave of converging ...

Clinical evidence is always evolving, but traditional clinical process map development and EHR build cycles often take months ...

ETX-19477 is a potent, selective inhibitor of poly (ADP-ribose) glycohydrolase (PARG), an enzyme that plays a role in the DNA ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a ...